Truqap ( Capivasertib ): a kinase inhibitor, in combination with Faslodex ( Fulvestrant ) for HR+ve, HER2-ve, breast cancer treatment
CPE point : 1 per event
This is an in-service training for the staff of St. Teresa's Hospital and St. Paul's Hospital
Date:
2026-01-09
Time:
5:30pm - 6:30pm
Organising Institute:
St. Teresa's Hospital and St. Paul's Hospital
Speaker:
PhD (Pharmaceutical Sciences) Emma Kang, Senior Medical Advisor, AstraZeneca
Related CPE Activities:
